Cargando…
PB2161: BORTEZOMIB, POMALIDOMIDE, AND DEXAMETHASONE IS AN EFFECTIVE REGIMEN FOR PATIENTS WITH RELAPSE AND REFRACTORY AL AMYLOIDOSIS AND MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASE
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428836/ http://dx.doi.org/10.1097/01.HS9.0000975404.43944.79 |
| _version_ | 1785090565545656320 |
|---|---|
| author | Liu, Yang Zhang, Qike Wen, Lei Wang, Shasha Dou, Xuelin Huang, Xiaojun Lu, Jin |
| author_facet | Liu, Yang Zhang, Qike Wen, Lei Wang, Shasha Dou, Xuelin Huang, Xiaojun Lu, Jin |
| author_sort | Liu, Yang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428836 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104288362023-08-17 PB2161: BORTEZOMIB, POMALIDOMIDE, AND DEXAMETHASONE IS AN EFFECTIVE REGIMEN FOR PATIENTS WITH RELAPSE AND REFRACTORY AL AMYLOIDOSIS AND MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASE Liu, Yang Zhang, Qike Wen, Lei Wang, Shasha Dou, Xuelin Huang, Xiaojun Lu, Jin Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428836/ http://dx.doi.org/10.1097/01.HS9.0000975404.43944.79 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Liu, Yang Zhang, Qike Wen, Lei Wang, Shasha Dou, Xuelin Huang, Xiaojun Lu, Jin PB2161: BORTEZOMIB, POMALIDOMIDE, AND DEXAMETHASONE IS AN EFFECTIVE REGIMEN FOR PATIENTS WITH RELAPSE AND REFRACTORY AL AMYLOIDOSIS AND MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASE |
| title | PB2161: BORTEZOMIB, POMALIDOMIDE, AND DEXAMETHASONE IS AN EFFECTIVE REGIMEN FOR PATIENTS WITH RELAPSE AND REFRACTORY AL AMYLOIDOSIS AND MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASE |
| title_full | PB2161: BORTEZOMIB, POMALIDOMIDE, AND DEXAMETHASONE IS AN EFFECTIVE REGIMEN FOR PATIENTS WITH RELAPSE AND REFRACTORY AL AMYLOIDOSIS AND MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASE |
| title_fullStr | PB2161: BORTEZOMIB, POMALIDOMIDE, AND DEXAMETHASONE IS AN EFFECTIVE REGIMEN FOR PATIENTS WITH RELAPSE AND REFRACTORY AL AMYLOIDOSIS AND MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASE |
| title_full_unstemmed | PB2161: BORTEZOMIB, POMALIDOMIDE, AND DEXAMETHASONE IS AN EFFECTIVE REGIMEN FOR PATIENTS WITH RELAPSE AND REFRACTORY AL AMYLOIDOSIS AND MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASE |
| title_short | PB2161: BORTEZOMIB, POMALIDOMIDE, AND DEXAMETHASONE IS AN EFFECTIVE REGIMEN FOR PATIENTS WITH RELAPSE AND REFRACTORY AL AMYLOIDOSIS AND MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASE |
| title_sort | pb2161: bortezomib, pomalidomide, and dexamethasone is an effective regimen for patients with relapse and refractory al amyloidosis and monoclonal immunoglobulin deposition disease |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428836/ http://dx.doi.org/10.1097/01.HS9.0000975404.43944.79 |
| work_keys_str_mv | AT liuyang pb2161bortezomibpomalidomideanddexamethasoneisaneffectiveregimenforpatientswithrelapseandrefractoryalamyloidosisandmonoclonalimmunoglobulindepositiondisease AT zhangqike pb2161bortezomibpomalidomideanddexamethasoneisaneffectiveregimenforpatientswithrelapseandrefractoryalamyloidosisandmonoclonalimmunoglobulindepositiondisease AT wenlei pb2161bortezomibpomalidomideanddexamethasoneisaneffectiveregimenforpatientswithrelapseandrefractoryalamyloidosisandmonoclonalimmunoglobulindepositiondisease AT wangshasha pb2161bortezomibpomalidomideanddexamethasoneisaneffectiveregimenforpatientswithrelapseandrefractoryalamyloidosisandmonoclonalimmunoglobulindepositiondisease AT douxuelin pb2161bortezomibpomalidomideanddexamethasoneisaneffectiveregimenforpatientswithrelapseandrefractoryalamyloidosisandmonoclonalimmunoglobulindepositiondisease AT huangxiaojun pb2161bortezomibpomalidomideanddexamethasoneisaneffectiveregimenforpatientswithrelapseandrefractoryalamyloidosisandmonoclonalimmunoglobulindepositiondisease AT lujin pb2161bortezomibpomalidomideanddexamethasoneisaneffectiveregimenforpatientswithrelapseandrefractoryalamyloidosisandmonoclonalimmunoglobulindepositiondisease |